Navigation Links
Jazz Pharmaceuticals Completes EUSA Pharma Acquisition
Date:6/12/2012

DUBLIN, June 12, 2012 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the closing of its acquisition of EUSA Pharma, a privately-held, specialty pharmaceutical company with a commercial presence in the U.S. and EU and a global distribution network. The acquisition brings a significant new specialty product to the company's U.S. product portfolio with Erwinaze™ (asparaginase Erwinia chrysanthemi), a life-saving treatment for patients with acute lymphoblastic leukemia.  Following the closing, Jazz Pharmaceuticals now also markets a portfolio of oncology and critical care products outside of the U.S., including Erwinase®, leveraging EUSA Pharma's international sales and marketing capabilities.

Jazz Pharmaceuticals acquired EUSA Pharma for $680 million in cash, which reflects a base price of $650 million and approximately $30 million of adjustments for EUSA's working capital, cash and certain liabilities, plus a potential $50 million milestone payable based upon Erwinaze achieving a specified U.S. net sales target in 2013.  The transaction was financed with cash on hand and proceeds from a six-year $475 million term loan with an initial interest rate based on a LIBOR rate, subject to a floor of 1.0 percent, plus 4.25 percent per annum.  Jazz Pharmaceuticals has also arranged a revolving credit facility for $100 million, which is undrawn and has a five year term.  Post-closing, the company's cash balance is in excess of $100 million.

"This transaction furthers our mission to improve patients' lives by growing our portfolio of specialty therapies that address significant medical needs," said Bruce Cozadd, chairman and chief executive officer of Jazz Pharmaceuticals. "The addition of EUSA Pharma as our new international business also expands our global footprint and brings additional marketed products and deve
'/>"/>

SOURCE Jazz Pharmaceuticals plc
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
2. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
3. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
4. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
5. Icahn Issues Statement Regarding Amylin Pharmaceuticals
6. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
7. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
8. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
9. Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference Call On May 8, 2012
10. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
11. Avanir Pharmaceuticals To Present at Three Conferences In May
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... 30, 2015 Velos, Inc., the pioneering software ... grow and add customers who receive Clinical and Translational ... CTSAs awarded by the National Institutes of Health currently ... is among the largest such market shares in its ... CTSA community keeps growing as a result of our ...
(Date:6/30/2015)... , June 30, 2015   Millar, Inc. ... technology, today announced the 2016 retirement of Craig ... Directors, after 12 years of service to the Company. ... named two senior members of the Executive Management team ... Tim Daugherty , currently Director of Sales and ...
(Date:6/30/2015)... , June 30, 2015 Olympus, ... innovative solutions for medical and surgical procedures, among ... next-day replacements for surgical equipment at no additional ... to offer this type of guarantee. The service ... Service Agreement earlier this year. ...
Breaking Medicine Technology:Velos continues adding CTSA customers - 40% now use Velos products 2Millar, Inc. Announces Leadership Changes 2Millar, Inc. Announces Leadership Changes 3Olympus Introduces Industry-First Next-Day Product Replacement Guarantee for Surgical Business 2Olympus Introduces Industry-First Next-Day Product Replacement Guarantee for Surgical Business 3
... 7, 2010 Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ... Review meeting with the U.S. Food and Drug Administration (FDA) ... the Company,s New Drug Application (NDA) for AZ-004 ( Staccato ... FDA in preparation for the meeting, with the responses or ...
... Dec. 7, 2010 Apexigen, Inc. announced today ... worldwide license agreement with Centocor Research & Development, ... therapeutic antibody technologies to discover and develop monoclonal ... to several targets specified by Centocor R&D, which ...
Cached Medicine Technology:Alexza Pharmaceuticals Provides Regulatory Update for AZ-004 (Staccato® Loxapine) 2Alexza Pharmaceuticals Provides Regulatory Update for AZ-004 (Staccato® Loxapine) 3Apexigen, Inc. Announces Collaboration for Antibody Discovery 2
(Date:6/30/2015)... , ... June 30, 2015 , ... White Blitz ... expanding its suite of products to mobile teeth whitening entrepreneurs. Mobile teeth whitening is ... that offer convenience and a personal touch. The popularity of the industry has spawn ...
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... Ticket Down is a reputable source of ... native of Detroit, MI, Kid Rock, is hitting the road again this summer in what ... and hip hop superstar kicked off his summer tour this year at the XFINITY Theatre ...
(Date:6/30/2015)... ... ... Institute of Personal Injury Attorneys (AIOPIA) awarded JTB Law Group, LLC as a firm, and ... As of July 1, 2015, the firm and Mr. Brown personally have been recognized ... The award is a culmination of the hard work, long hours, and excellent results the ...
(Date:6/30/2015)... ... June 30, 2015 , ... Earlier this month Wound Care ... Course. Clinicians from WCA partnering hospitals across the country, met in Anaheim, California ... and hyperbaric medicine education and training is something that is never complete. Even ...
(Date:6/30/2015)... ... June 30, 2015 , ... Trenton Health Team has been ... Medicaid Accountable Care Organizations (ACO) in the State, serving the greater Trenton community. ... Trenton Health Team ACO draws on the collaborative structure of THT, bringing together the ...
Breaking Medicine News(10 mins):Health News:White Blitz to Develop New Mobile Teeth Whitening Program for Entrepreneurs 2Health News:Cheap Kid Rock Tickets at the DTE Energy Music Theatre in Clarkston: Ticket Down Has Slashed Prices On All Kid Rock Tickets at DTE in the Detroit Metro Area 2Health News:JTB Law Group, LLC Recognized as a Top 10 Best Law Firm by AIOPIA 2Health News:Wound Care Advantage Hosts Its First UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 2Health News:Wound Care Advantage Hosts Its First UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 3Health News:Trenton Health Team Certified as Medicaid Accountable Care Organization 2Health News:Trenton Health Team Certified as Medicaid Accountable Care Organization 3
... ... at ITEXPO , ... CA, ITEXPO West 2009 (PRWEB) September 3, 2009 -- FaxBack®, a leading provider of ... program for a new fax ATA device, based on HTTPS, which provides a superior level ...
... ... , ... September 3, 2009 -- Today,s challenging business environment requires companies to maximize valuable resources ... staffs, the reliance on outside consultants to accomplish these strategies becomes not just a ...
... , , PHOENIX, Sept. 2 ... southwestern United States, has formed a strategic alliance with American National ... getting claims compensated in a timely manner with a proprietary process ... , , "Over the last 10 years ...
... MONTREAL, Sept. 2 With five years and ... manufacturers (Sirona, Meisinger, SycoTec - R&D spin off of ... products nationwide in Canada with an exclusive multimillion-dollar agreement ... Patterson has operations in Vancouver, Edmonton, Calgary, London, Toronto, ...
... , , , ... Martek Biosciences Corporation (Nasdaq: MATK ) today announced its financial results ... $77.8 million, down 12% from $88.4 million in the third quarter of fiscal ... third quarter of fiscal 2009, a 4% decrease compared with $9.3 million, or ...
... , NEW YORK , Sept. 2 In the ... don,t have to shout to be heard. A pioneer in the eHealth ... online call for a careful, strategic approach to reform is attracting the ... as everyday Americans currently struggling to pay their medical bills. , ...
Cached Medicine News:Health News:FaxBack Announces a New VoIP Fax ATA, based on HTTPS, Which Provides a Level of Quality for VoIP Faxing Equal to PSTN Connections 2Health News:Find Qualified Consulting Firms Quickly and Efficiently 2Health News:Find Qualified Consulting Firms Quickly and Efficiently 3Health News:ProDrive Systems Announces Exclusive Distribution Agreement with Patterson Dental Canada 2Health News:Martek Announces Third Quarter 2009 Financial Results 2Health News:Martek Announces Third Quarter 2009 Financial Results 3Health News:Martek Announces Third Quarter 2009 Financial Results 4Health News:Martek Announces Third Quarter 2009 Financial Results 5Health News:Martek Announces Third Quarter 2009 Financial Results 6Health News:Martek Announces Third Quarter 2009 Financial Results 7Health News:Martek Announces Third Quarter 2009 Financial Results 8Health News:Martek Announces Third Quarter 2009 Financial Results 9Health News:Martek Announces Third Quarter 2009 Financial Results 10Health News:Martek Announces Third Quarter 2009 Financial Results 11Health News:Martek Announces Third Quarter 2009 Financial Results 12Health News:Healthcare Debate: One Citizen's Call for Calm Catches On 2
The CKMB method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of creatine kinase MB isoenzyme activity in serum and plasma...
For the quantitative in vitro determination of Cholesterol in serum and plasma....
The ALP method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of alkaline phosphatase activity in serum or plasma....
The Tag-It™ Cystic Fibrosis ASR reagents can be used by high complexity CLIA approved laboratories for detection of up to 70 mutations and 6 variants (polymorphisms) in the cystic fibrosis tran...
Medicine Products: